-
As Omicron Spreads, Child Hospitalizations Climb 30% in Past Week
Drugs
December 29, 2021
Child hospitalizations for COVID-19 jumped 30% this past week as the Omicron variant spread like wildfire throughout the United States.
-
UAE approves Sinopharm’s protein-based vaccine
ExpressPharma
December 29, 2021
The United Arab Emirates (UAE) has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.
-
As Omicron Spreads, Child Hospitalizations Climb 30 Percent in Past Week
drugs
December 28, 2021
Child hospitalizations for COVID-19 jumped 30 percent this past week as the omicron variant spread like wildfire throughout the United States.
-
Novavax Covid vaccine could win Dutch approval Friday as mRNA alternative
FirstWordPharma
December 27, 2021
The Dutch Health Council recommended that adults who are unvaccinated against COVID-19, and object to using vaccines based on newer mRNA techniques...
-
AstraZeneca’s Vaccine, Dumped by the West, Helps Fill Gaping Need in Rest of World
FirstWordPharma
December 27, 2021
AstraZeneca's COVID-19 vaccine Vaxzevria in not authorised in the US, and other countries such as Canada, Australia and those in Western Europe have shunned it after production problems
-
Netherlands approves Novavax Covid vaccine; Won't use Janssen boosters
FirstWordPharma
December 27, 2021
The Netherlands has approved the use of Novavax's protein-based COVID-19 vaccine Nuvaxovid, reported NL Times.
-
COVID-19 vaccine should be offered to vulnerable children aged five to 11-years-old
pharmatimes
December 23, 2021
Government vaccine advisers have said vulnerable primary school children should be offered a low-dose of a COVID-19 vaccine.
-
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
AmericanPharmaceuticalReview
December 22, 2021
Pfizer Inc. and BioNTech SE announced an agreement has been reached with the European Commission (EC) and its member states to exercise an option to purchase more than 200 million additional doses of COMIRNATY®...
-
COVID-19 vaccine protection wanes after three months, study suggests
WorldPharmaNews
December 22, 2021
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses, a study says.
-
Bharat Biotech seeks approval for Phase III intranasal Covid-19 vaccine trial
Pharmaceutical-Technology
December 22, 2021
Indian company Bharat Biotech has filed an application with the Drugs Controller General of India (DCGI) seeking approval to commence Phase III clinical trial for its intranasal Covid-19 vaccine BBV154.